Bahram Valamehr, Chief R&D Officer at FATE THERAPEUTICS INC (FATE), sold 8,722 shares at $48.44 ($423K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Seasonal sale ($423k) by Chief R&D Officer — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.44 | 4,152 | $201K | 47.6% |
| 2 | $48.44 | 4,152 | $201K | 47.6% |
| 3 | $49.12 | 418 | $21K | 4.9% |
| Total | $48.47 avg | 8,722 | $423K | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |